*The following content is generated by AI and is for reference only.
Overview
Semaglutide main chain intermediate (CAS 1169630-82-3) is a critical peptide precursor for GLP-1 receptor agonists. Synthesized via solid-phase peptide synthesis, it features a specific protected backbone structure. The molecular formula is C45H73N9O11.
Application
- Pharmaceutical Manufacturing: Essential building block for synthesizing semaglutide injectables.
- Research & Development: Used in process optimization and stability studies for anti-diabetic drugs.
- Clinical Supply Chain: Supports large-scale production of obesity and type 2 diabetes therapies.
Precautions
Store under inert atmosphere at -20°C to prevent degradation. Handle with appropriate PPE due to potential sensitization risks. Strictly controlled for pharmaceutical use only; not for direct human administration without formulation.